ICR Acquires Westwicke Partners, North America’s Leading Healthcare-Focused IPO Advisor & Investor Relations Firm. Learn More

Westicke Partners

Mobile Navigation

David Clair, CFA

Dave has been exclusively focused on advising Medical Technology, Diagnostics & Life Science Tools companies since joining the firm in 2015. Dave has developed strong relationships with public and private companies covering the landscape of medical technology and healthcare services including: Abbott, BioScrip, Bio-Techne, CareDx, CVR Medical, Femasys, Pixium Vision, US Medical Innovations and Zimmer Biomet.

Biography

David Clair

Prior to joining the firm, Dave spent over 9 years on Piper Jaffray’s medical technology equity research team as an Associate Vice President. During Dave’s tenure at Piper Jaffray, the team successfully brought several companies through the IPO process including CareDx, Masimo, Fluidigm, Oxford Immunotec and Pacific Biosciences. Dave’s background also includes 2 years on RBC Capital Market’s medical technology team researching companies in the diagnostics and orthopedics industries. Dave leverages his extensive sell-side background and medical technology sector knowledge to create effective, company specific investor relations strategies with the goal of educating current and potential investors and maximizing valuation.

Dave holds a B.A in Accounting from Michigan State University, a M.B.A. from the University of Minnesota and received his Chartered Financial Analyst designation in 2003. Dave lives in Minneapolis, Minnesota with his wife Connie and sons, Connor and Tyler.

ICR ACQUIRES WESTWICKE PARTNERS

Westwicke will operate as ICR’s healthcare practice and integrate ICR’s capabilities. Read more in the press release announcement.

Our Locations